Organogenesis Holdings Stock Forecast - Simple Moving Average

ORGO Stock  USD 3.92  0.08  2.00%   
The Simple Moving Average forecasted value of Organogenesis Holdings on the next trading day is expected to be 3.92 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 13.80. Organogenesis Stock Forecast is based on your current time horizon. Although Organogenesis Holdings' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Organogenesis Holdings' systematic risk associated with finding meaningful patterns of Organogenesis Holdings fundamentals over time.
As of today the rsi of Organogenesis Holdings' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Organogenesis Holdings' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Organogenesis Holdings, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Organogenesis Holdings' stock price prediction:
Quarterly Earnings Growth
0.222
EPS Estimate Next Quarter
0.18
EPS Estimate Current Year
0.22
EPS Estimate Next Year
0.17
Wall Street Target Price
8.5
Using Organogenesis Holdings hype-based prediction, you can estimate the value of Organogenesis Holdings from the perspective of Organogenesis Holdings response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Organogenesis Holdings using Organogenesis Holdings' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Organogenesis using crowd psychology based on the activity and movement of Organogenesis Holdings' stock price.

Organogenesis Holdings Short Interest

An investor who is long Organogenesis Holdings may also wish to track short interest. As short interest increases, investors should be becoming more worried about Organogenesis Holdings and may potentially protect profits, hedge Organogenesis Holdings with its derivative instruments, or be ready for some potential downside.
200 Day MA
4.3988
Short Percent
0.2978
Short Ratio
8.27
Shares Short Prior Month
11.3 M
50 Day MA
4.9728

Organogenesis Holdings Hype to Price Pattern

Investor biases related to Organogenesis Holdings' public news can be used to forecast risks associated with an investment in Organogenesis. The trend in average sentiment can be used to explain how an investor holding Organogenesis can time the market purely based on public headlines and social activities around Organogenesis Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Organogenesis Holdings Implied Volatility

    
  2.38  
Organogenesis Holdings' implied volatility exposes the market's sentiment of Organogenesis Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Organogenesis Holdings' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Organogenesis Holdings stock will not fluctuate a lot when Organogenesis Holdings' options are near their expiration.
The Simple Moving Average forecasted value of Organogenesis Holdings on the next trading day is expected to be 3.92 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 13.80.

Organogenesis Holdings after-hype prediction price

    
  USD 3.87  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Organogenesis Holdings to cross-verify your projections.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.

Open Interest Against 2026-04-17 Organogenesis Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Organogenesis Holdings' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Organogenesis Holdings' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Organogenesis Holdings stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Organogenesis Holdings' open interest, investors have to compare it to Organogenesis Holdings' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Organogenesis Holdings is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Organogenesis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Organogenesis Holdings Additional Predictive Modules

Most predictive techniques to examine Organogenesis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Organogenesis using various technical indicators. When you analyze Organogenesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for Organogenesis Holdings is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Organogenesis Holdings Simple Moving Average Price Forecast For the 26th of January

Given 90 days horizon, the Simple Moving Average forecasted value of Organogenesis Holdings on the next trading day is expected to be 3.92 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.16, and the sum of the absolute errors of 13.80.
Please note that although there have been many attempts to predict Organogenesis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Organogenesis Holdings' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Organogenesis Holdings Stock Forecast Pattern

Backtest Organogenesis HoldingsOrganogenesis Holdings Price PredictionBuy or Sell Advice 

Organogenesis Holdings Forecasted Value

In the context of forecasting Organogenesis Holdings' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Organogenesis Holdings' downside and upside margins for the forecasting period are 0.04 and 11.08, respectively. We have considered Organogenesis Holdings' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.92
3.92
Expected Value
11.08
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Organogenesis Holdings stock data series using in forecasting. Note that when a statistical model is used to represent Organogenesis Holdings stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.6026
BiasArithmetic mean of the errors 0.0065
MADMean absolute deviation0.234
MAPEMean absolute percentage error0.0452
SAESum of the absolute errors13.805
The simple moving average model is conceptually a linear regression of the current value of Organogenesis Holdings price series against current and previous (unobserved) value of Organogenesis Holdings. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Organogenesis Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Organogenesis Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.193.8711.03
Details
Intrinsic
Valuation
LowRealHigh
0.255.0312.19
Details
4 Analysts
Consensus
LowTargetHigh
7.748.509.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Organogenesis Holdings. Your research has to be compared to or analyzed against Organogenesis Holdings' peers to derive any actionable benefits. When done correctly, Organogenesis Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Organogenesis Holdings.

Organogenesis Holdings After-Hype Price Prediction Density Analysis

As far as predicting the price of Organogenesis Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Organogenesis Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Organogenesis Holdings, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Organogenesis Holdings Estimiated After-Hype Price Volatility

In the context of predicting Organogenesis Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Organogenesis Holdings' historical news coverage. Organogenesis Holdings' after-hype downside and upside margins for the prediction period are 0.19 and 11.03, respectively. We have considered Organogenesis Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.92
3.87
After-hype Price
11.03
Upside
Organogenesis Holdings is risky at this time. Analysis and calculation of next after-hype price of Organogenesis Holdings is based on 3 months time horizon.

Organogenesis Holdings Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Organogenesis Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organogenesis Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Organogenesis Holdings, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.07 
7.16
  0.05 
  0.02 
24 Events / Month
7 Events / Month
In about 24 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.92
3.87
1.28 
967.57  
Notes

Organogenesis Holdings Hype Timeline

Organogenesis Holdings is now traded for 3.92. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of -0.02. Organogenesis is forecasted to decline in value after the next headline, with the price expected to drop to 3.87. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.28%, whereas the daily expected return is now at 0.07%. The volatility of related hype on Organogenesis Holdings is about 3182.22%, with the expected price after the next announcement by competition of 3.90. About 47.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Organogenesis Holdings recorded a loss per share of 0.08. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 24 days.
Check out Historical Fundamental Analysis of Organogenesis Holdings to cross-verify your projections.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.

Organogenesis Holdings Related Hype Analysis

Having access to credible news sources related to Organogenesis Holdings' direct competition is more important than ever and may enhance your ability to predict Organogenesis Holdings' future price movements. Getting to know how Organogenesis Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Organogenesis Holdings may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SNDLSNDL Inc 0.04 18 per month 0.00 (0.10) 5.06 (5.88) 37.98 
MNPRMonopar Therapeutics 0.53 21 per month 3.66 (0.02) 5.36 (5.27) 18.89 
EBSEmergent Biosolutions 0.47 14 per month 4.11  0.06  8.06 (4.53) 52.54 
ESPREsperion Therapeutics(0.20)11 per month 4.19  0.04  7.05 (7.04) 24.91 
EOLSEvolus Inc(0.17)16 per month 0.00 (0.13) 5.43 (5.29) 19.71 
SIGASIGA Technologies 0.47 10 per month 0.00 (0.13) 3.56 (3.08) 23.51 
ANGOAngioDynamics(0.38)10 per month 0.00 (0.08) 4.34 (4.55) 18.26 
BCYCBicycle Therapeutics(3.61)11 per month 0.00 (0.07) 6.06 (5.88) 17.28 
VREXVarex Imaging Corp 0.07 8 per month 3.12  0.08  4.43 (3.53) 18.19 
CMPXCompass Therapeutics 0.53 14 per month 3.20  0.14  7.61 (5.86) 16.14 

Other Forecasting Options for Organogenesis Holdings

For every potential investor in Organogenesis, whether a beginner or expert, Organogenesis Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Organogenesis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Organogenesis. Basic forecasting techniques help filter out the noise by identifying Organogenesis Holdings' price trends.

Organogenesis Holdings Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Organogenesis Holdings stock to make a market-neutral strategy. Peer analysis of Organogenesis Holdings could also be used in its relative valuation, which is a method of valuing Organogenesis Holdings by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Organogenesis Holdings Market Strength Events

Market strength indicators help investors to evaluate how Organogenesis Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Organogenesis Holdings shares will generate the highest return on investment. By undertsting and applying Organogenesis Holdings stock market strength indicators, traders can identify Organogenesis Holdings entry and exit signals to maximize returns.

Organogenesis Holdings Risk Indicators

The analysis of Organogenesis Holdings' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Organogenesis Holdings' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting organogenesis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Organogenesis Holdings

The number of cover stories for Organogenesis Holdings depends on current market conditions and Organogenesis Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Organogenesis Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Organogenesis Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Organogenesis Holdings Short Properties

Organogenesis Holdings' future price predictability will typically decrease when Organogenesis Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Organogenesis Holdings often depends not only on the future outlook of the potential Organogenesis Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organogenesis Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding131.7 M
Cash And Short Term Investments135.6 M
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out Historical Fundamental Analysis of Organogenesis Holdings to cross-verify your projections.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.222
Earnings Share
(0.08)
Revenue Per Share
3.651
Quarterly Revenue Growth
0.31
Return On Assets
0.0018
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.